Growth Parameters and Vitamin D status in Children with Thalassemia Major in Upper Egypt
,
Abstract
Aim: the aim of this study is to assess the growth parameters, vitamin D, calcium, and phosphorous status in children with thalassemia major receiving packed red cells transfusion with chelation therapy.
Patients and Methods: In a case control study, 100 patients with beta thalassemia major (aged from 4 to 15 years) were compared with 100 sex- and age-matched children serves as a control group. Anthropometric measurement, Serum level of calcium, phosphorus and vitamin D (25 hydroxycholecalciferol) were estimated for all patients & controls.
Results: 49% of our patients had short stature. 47% were underweight. BMI of 43 (43%) patients were low. The mean total serum calcium (6.6±1.2 mg/dl) and 25-hydroxycholecalciferol (25-OH Vit D) (10.4±4.6 mcg/dl) levels were significantly lower in our patients than in controls (10.2±1.06 mg/dl and 40.2±12.3 mcg/dl, respectively); each P< 0.001.
Conclusion: Children with beta thalassemia major have delayed growth and metabolic abnormalities that signify the importance of therapeutic interventions. The presence of these abnormalities may be due to iron overload and poor nutritional support.
Kesse-Adu R & Howard J. Inherited anaemias: sickle cell and thalassaemia. Medicine. 2013; 41, 4. 219-24.
Higgs DR, Engel JD, Stamatoyannopoulos G. Thalassaemia. Lancet. 2012; Jan 28; 379 (9813): 373 - 83.
Hussein G , Fawzy M, Serafi TE, et al. Rapid detection of beta thalassemia alleles in Egypt using naturally or amplified created restriction sites and direct sequencing: a step in disease control. Hemoglobin, 2007; 31 (1) pp. 49–62.
Shawky RM & Kamal TM. Thalassemia intermedia: An overview. Egypt J Med Hum Genet, 2012; 13, pp. 245–55.
Perrotta S, Gallagher PG, Mohandas N. Hereditary spherocytosis. Lancet. 2008; 372: 1411-26.
Satwani H, Raza J, Alam M, et al. Endocrine Complications in Thalassemias: Frequency and Association with Serum Ferritin Levels. Pak Paediat Assoc J. 2005; 29: 113-9.
Raiola G, Galati MC, De Sanctis V, et al. Growth and puberty in thalassemia major. J Pediatr Endocrinol Metab. 2003 Mar; 16 S 2:259-66.
Bielinski BK, Darbyshire PJ, Mathers L, et al. Impact of disordered puberty on bone density in beta thalassemia major. Br J Hematol. 2003; 120:353-8.
Soliman A., Adel A., Wagdy M., et al. Calcium homeostasis in 40 adolescents with beta-thalassemia major: a case control study of the effects of intramuscular injection of a megadose of cholecalciferol. Pediatr Endocrinol Rev. 2008; 6(1): 149–154.
Tsitoura S, Amarilio N, Lapatsani P, et al. Serum 25 hydroxy vitamin D levels in thalassemia. Arch Dis Child. 1978, 53:347.
Giardina PJ, Forget BG. Thalassemia syndromes. In: Hoffman R, Benz EJ, Shattil SS, et al., eds. Hematology: Basic Principles and Practice. 5th ed. Philadelphia, Pa: Elsevier Churchill Livingstone; 2008: chap 41.
WHO Anthro (version 3.2.2, 2011). Software for assessing growth and development of the world's children. Geneva: WHO, 2011. http://www.who.int/childgrowth/software/en/.
Fiske, H., Subbarow, Y. The colorimetric determination of phosphorus. J Biol Chem. 66: 375, 1925.
Hashemi A, Ghilian R, Golestan M. et al. The study of growth in thalassemic patients and its correlation with serum ferritin level. IJPHO. 2011; 1 (4).147-51.
Vogiatzi MG, Macklin EA, Trachtenberg FL. et al. Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassemia syndromes in North America. Br J Haematol. 2009 Sep; 146(5):546-56.
Jain M, Sinha RS, Chellani H, Anand NK. Assessment of thyroid functions and its role in body growth in thalassemia major. Indian Pediatr. 1995 Feb;32(2):213-9.
Shamshirsaz A, Bekheirnia M, Kamgar M, et al. Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Tehran. BMC Endocrine Disorder. 2003; 3: 4-13. 16.
Flynn DM, Fairney A, Jackson D, et al. Hormonal changes in thalassemia major. Arch Dis child. 1976; 51:828-36.
Chekir A, Laradi S, Ferchichi S, et al. Oxidant, antioxidant status and metabolic data in patients with beta thalassemia. Clinica Chimica Acta. 2003, 338: 79-86.
Hamed E A & El-Melegy NT: Renal functions in pediatric patients with beta-thalassemia major: relation to chelation therapy: original prospective study. Ital J Pediatr. 2010; 36: 39.
Pirinççioğlu AG, Akpolat V, Köksal O, Haspolat K, Söker M. Bone mineral density in children with beta-thalassemia major in Diyarbakir. Bone. 2011; Oct; 49(4):819-23.
Napoli N., Carmena E., Bucchieri S., et al. Low serum levels of 25-hydroxy vitamin D in adults affected by thalassemia major or intermedia. Bone 2006; 38: 888–892.
Claster S, Wood JC, Noetzli L, et al. Nutritional deficiencies in iron overloaded patients with hemoglobinopathies. Am J Hematol. 2009; 84: 344–8.
Zamboni G, Marradi P, Tagliaro F, et al. Parathyroid hormone, calcitonin and vitamin D metabolites in beta thalassemia major. Euro J Pediatr. 1986;145:133–6.
De-Sanctis V, Vullo C, Bagni B, et al.. Hyperparathyroidism in beta thalassemia major: clinical and laboratory observations in 24 patients. Acta Hematol. 1992; 88:105–8.
Aleem A, AL-Momen AK, Al-Harakati MS, et al. Hypocalcemia due to hypoparathyroidism in b-thalassemia major patients. Ann Saudi Med. 2000; 20:364–6.
Autio KA, Mait JE, Lesser M, et al. Low bone mineral density in adolescents with b-thalassemia. J NY Acad Sci. 2005; 1054:462.
Goyal M, Abrol P, Lal H. Parathyroid and Calcium Status in Patients with Thalassemia. Ind J Clin Biochem. 2010; 25(4):385–387.
Mahachoklertwattana P, Chuansumrit A, Choubtum L, et al. Bone mineral density in children and young adults with beta-thalassemia trait. J Pediatr Endocrinol Metab. 2002; 15:1531–5.
Di Stefano M, Chiabotto P, Roggia C, et al. Bone mass and metabolism in thalassemic children and adolescents treated with different iron-chelating drugs. J Bone Miner Metab. 2004; 22:53–7.
Eren E, Yilmaz N. Biochemical markers of bone turnover and bone mineral density in patients with b-thalassemia major. Int J Clin Pract. 2005; 59(1):46–51.
Soliman AT, Banna EI, Abdel Fattah M. Bone mineral density in prepubertal children with beta-thalassemia: correlation with growth and hormonal data. Metabolism. 1998; 47:541–8.
Salama OS, Al-Tonbary YA, Shahin RR, Eldeen OA. Unbalanced bone turnover in children with beta-thalassemia. Hematology. 2006; 11(3):197–202.
| Files | ||
| Issue | Vol 7, No 4 (2013) | |
| Section | Articles | |
| Keywords | ||
| Calcium Growth Thalassemia major Vitamin D | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
